Clinical Trials Directory

Trials / Sponsors / Unity Biotechnology, Inc.

Unity Biotechnology, Inc.

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
CompletedAssess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DM
Diabetic Macular Edema, Retinal Disease, Macular Edema
Phase 22023-08-23
CompletedSafety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degenerat
Neovascular Age-related Macular Degeneration
Phase 22022-03-02
CompletedSafety, Tolerability and Evidence of Activity Study of UBX1325 in Patients With Diabetic Macular Edema (BEHOLD
Diabetic Macular Edema (DME)
Phase 22021-06-25
CompletedSafety and Tolerability Study of UBX1325 in Patients With Diabetic Macular Edema or Neovascular Age-Related Ma
Diabetic Macular Edema, Neovascular Age-related Macular Degeneration
Phase 12020-10-08
TerminatedLong-Term Follow-Up Study of Patients With Osteoarthritis of the Knee Treated With UBX0101 or Placebo
Knee Osteoarthritis
—2020-04-20
CompletedA Study of Single and Repeat Dose Administration of UBX0101 in Patients With Osteoarthritis of the Knee
Knee Osteoarthritis
Phase 12020-01-23
CompletedA Study to Assess the Safety and Efficacy of a Single Dose of UBX0101 in Patients With Osteoarthritis of the K
Osteoarthritis, Knee
Phase 22019-10-30
CompletedA Safety and Tolerability Study of UBX0101 in Patients With Osteoarthritis of the Knee
Osteoarthritis, Knee
Phase 12018-05-16
CompletedAn Exploratory Clinical Study to Investigate Biomarkers of Senescence in Patients With Osteoarthritis of the K
Osteoarthritis, Knee
N/A2017-03-02